BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23580564)

  • 1. Activity of biapenem (RPX2003) combined with the boronate β-lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae.
    Livermore DM; Mushtaq S
    J Antimicrob Chemother; 2013 Aug; 68(8):1825-31. PubMed ID: 23580564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters.
    Mushtaq S; Woodford N; Hope R; Adkin R; Livermore DM
    J Antimicrob Chemother; 2013 Jul; 68(7):1601-8. PubMed ID: 23449829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of Biapenem plus RPX7009, a carbapenem combined with a serine β-lactamase inhibitor, against anaerobic bacteria.
    Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2620-30. PubMed ID: 23529731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
    Mushtaq S; Vickers A; Woodford N; Livermore DM
    J Antimicrob Chemother; 2017 Jun; 72(6):1688-1695. PubMed ID: 28333319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa.
    Livermore DM; Warner M; Mushtaq S
    J Antimicrob Chemother; 2013 Oct; 68(10):2286-90. PubMed ID: 23696619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.
    Livermore DM; Warner M; Mushtaq S; Doumith M; Zhang J; Woodford N
    Int J Antimicrob Agents; 2011 May; 37(5):415-9. PubMed ID: 21429716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae.
    Lomovskaya O; Sun D; Rubio-Aparicio D; Nelson K; Tsivkovski R; Griffith DC; Dudley MN
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases.
    Livermore DM; Mushtaq S; Warner M; Miossec C; Woodford N
    J Antimicrob Chemother; 2008 Nov; 62(5):1053-6. PubMed ID: 18689875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates.
    Livermore DM; Mushtaq S; Warner M; Zhang JC; Maharjan S; Doumith M; Woodford N
    J Antimicrob Chemother; 2011 Jan; 66(1):48-53. PubMed ID: 21078604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of carbapenems with ME1071 (disodium 2,3-diethylmaleate) against Enterobacteriaceae and Acinetobacter spp. with carbapenemases, including NDM enzymes.
    Livermore DM; Mushtaq S; Morinaka A; Ida T; Maebashi K; Hope R
    J Antimicrob Chemother; 2013 Jan; 68(1):153-8. PubMed ID: 22945917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of Meropenem Combined with RPX7009, a Novel β-Lactamase Inhibitor, against Gram-Negative Clinical Isolates in New York City.
    Lapuebla A; Abdallah M; Olafisoye O; Cortes C; Urban C; Quale J; Landman D
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4856-60. PubMed ID: 26033723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin.
    Giske CG; Gezelius L; Samuelsen Ø; Warner M; Sundsfjord A; Woodford N
    Clin Microbiol Infect; 2011 Apr; 17(4):552-6. PubMed ID: 20597925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time TaqMan PCR for rapid detection of genes encoding five types of non-metallo- (class A and D) carbapenemases in Enterobacteriaceae.
    Swayne RL; Ludlam HA; Shet VG; Woodford N; Curran MD
    Int J Antimicrob Agents; 2011 Jul; 38(1):35-8. PubMed ID: 21549572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.
    Pfaller MA; Huband MD; Mendes RE; Flamm RK; Castanheira M
    Int J Antimicrob Agents; 2018 Aug; 52(2):144-150. PubMed ID: 29510189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in-vitro activity of biapenem against enterobacteria with beta-lactamase-mediated antibiotic resistance.
    Chen HY; Livermore DM
    J Antimicrob Chemother; 1994 Mar; 33(3):453-64. PubMed ID: 8040111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamases.
    Livermore DM; Mushtaq S; Warner M; Woodford N
    J Antimicrob Chemother; 2015 Nov; 70(11):3032-41. PubMed ID: 26311835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
    Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
    Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of chequerboard combinations of ceftaroline and NXL104 versus beta-lactamase-producing Enterobacteriaceae.
    Mushtaq S; Warner M; Williams G; Critchley I; Livermore DM
    J Antimicrob Chemother; 2010 Jul; 65(7):1428-32. PubMed ID: 20478991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
    Stock I
    Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MULTIRESISTANT BACTERIA].
    Bedenić B; Sardelić S; Ladavac M
    Acta Med Croatica; 2015 Sep; 69(3):211-6. PubMed ID: 29077379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.